FIN
Life Sciences
Technology is revolutionising every corner of the life sciences industry, bringing ground-breaking new therapies to the market and harnessing big data to drive the transformation of global healthcare.
Leaders in life sciences need to be visionary and passionate advocates for innovation, balancing the commercial, operational and scientific complexities that deliver value to shareholders and patients.
Odgers Berndtson Global Life Sciences Practice works on senior commercial, scientific and technical appointments across biopharma and medical devices, supporting organisations of all shapes and sizes, from start-up and early-stage through to established global leaders. Find out what makes us your ideal Executive Search partner.
Finland
The European pharmaceuticals market remains in a frustrating position as Europe’s fragmented nature becomes increasingly clear in the wake of the Eurozone crisis.
Ageing populations, growth in emerging markets, and a flood of new technologies should all have spurred growth in the European pharma market. But complex compliance requirements, cash strapped governments, and increasing regulation have reined in pharma’s growth in Europe.
Odgers Berndtson’s global Life Sciences Practice works with pharmaceutical, biotechnology, outsourcing and analytics companies to revitalise their leadership teams and secure growth in Europe and beyond.
